AT Bancorp decreased its position in shares of Metlife Inc (NYSE:MET) by 41.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,378 shares of the financial services provider’s stock after selling 7,996 shares during the period. AT Bancorp’s holdings in Metlife were worth $575,000 at the end of the most recent reporting period.
Other large investors also recently made changes to their positions in the company. Aspen Investment Management Inc grew its stake in shares of Metlife by 0.7% in the second quarter. Aspen Investment Management Inc now owns 7,178 shares of the financial services provider’s stock worth $394,000 after purchasing an additional 50 shares during the last quarter. Fairfield Bush & CO. lifted its holdings in shares of Metlife by 1.7% during the second quarter. Fairfield Bush & CO. now owns 6,150 shares of the financial services provider’s stock valued at $338,000 after purchasing an additional 100 shares during the last quarter. Sentry Investment Management LLC lifted its holdings in shares of Metlife by 0.8% during the second quarter. Sentry Investment Management LLC now owns 82,321 shares of the financial services provider’s stock valued at $4,523,000 after purchasing an additional 690 shares during the last quarter. QS Investors LLC lifted its holdings in shares of Metlife by 6.0% during the second quarter. QS Investors LLC now owns 17,337 shares of the financial services provider’s stock valued at $952,000 after purchasing an additional 988 shares during the last quarter. Finally, Cowen Prime Services LLC lifted its holdings in shares of Metlife by 16.0% during the third quarter. Cowen Prime Services LLC now owns 7,250 shares of the financial services provider’s stock valued at $377,000 after purchasing an additional 1,000 shares during the last quarter. 76.55% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Metlife Inc (NYSE MET) traded up $0.21 during midday trading on Wednesday, hitting $45.41. 2,297,935 shares of the stock traded hands, compared to its average volume of 8,075,909. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.16 and a quick ratio of 0.16. Metlife Inc has a 52-week low of $43.38 and a 52-week high of $55.91. The stock has a market cap of $47,560.00, a PE ratio of 10.52, a price-to-earnings-growth ratio of 1.00 and a beta of 1.31.
Metlife (NYSE:MET) last posted its quarterly earnings data on Tuesday, February 13th. The financial services provider reported $0.64 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.05 by ($0.41). Metlife had a positive return on equity of 8.81% and a negative net margin of 0.75%. During the same quarter in the previous year, the business earned $1.28 earnings per share. equities analysts forecast that Metlife Inc will post 4.42 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 13th. Shareholders of record on Monday, February 5th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Friday, February 2nd. This represents a $1.60 dividend on an annualized basis and a yield of 3.52%. Metlife’s dividend payout ratio is currently 36.87%.
A number of equities analysts recently weighed in on MET shares. Wells Fargo & Co set a $60.00 price objective on shares of Metlife and gave the stock a “buy” rating in a report on Tuesday. Morgan Stanley decreased their price objective on shares of Metlife from $59.00 to $58.00 and set an “equal weight” rating for the company in a report on Wednesday. ValuEngine downgraded shares of Metlife from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 2nd. Goldman Sachs Group reaffirmed a “buy” rating on shares of Metlife in a research report on Wednesday, January 31st. Finally, B. Riley reaffirmed a “neutral” rating on shares of Metlife in a research report on Monday, November 6th. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating and nine have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $57.77.
ILLEGAL ACTIVITY NOTICE: “Metlife Inc (NYSE:MET) Shares Sold by AT Bancorp” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/14/at-bancorp-reduces-position-in-metlife-inc-met.html.
Metlife Company Profile
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.